On Friday, IGI Laboratories, Inc. (NYSEMKT:IG)’s shares inclined 19.03% to $8.07.
IGI Laboratories, Inc. (IG), a New Jersey-based specialty generic pharmaceutical company, declared its financial results for the second quarter ended June 30, 2015.
Second Quarter 2015 Highlights
- Total revenues of $8.9 million in the second quarter of 2015, an enhance of 37% over the same quarter in 2014
- Total net revenues generated from the sale of IGI label generic topical pharmaceutical products for the three months ended June 30, 2015 and 2014 of $6.7 million and $3.4 million, respectively
- Gross profit for the three months ended June 30, 2015 equaled 41% as contrast to 45% in the same period in 2014
- IGI filed four Abbreviated New Drug Applications (ANDAs) in the second quarter of 2015 with the U.S. Food and Drug Administration (FDA)
- Operating loss was $1.9 million in the second quarter of 2015 contrast to $0.3 million in the same period in 2014, primarily attributable to an enhance in research and development costs of $1.4 million over the same period in 2014
IGI Laboratories, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets topical formulations in the United States. It sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms under IGI label. The company also develops, manufactures, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, in addition to for over-the-counter (OTC) and cosmetic markets.
Opko Health Inc. (NYSE:OPK)’s shares dropped -1.80% to $16.90.
Opko Health Inc. (OPK) may fit the first condition of being at or near its highs, but it does not fulfill the second. Those short Opko don’t seem to mind all that much, being that 44.92M shares are presently held short, constituting 67% of the float. That’s about a million more shares than last month, representing over $15M in capital spent on shorting the stock in one month, at least.
While shorting itself may tend to discourage some retail investors from taking a position, institutional investors in addition to company insiders are usually astute enough to know that for every short seller, there is a buyer of those shares on the other side. Close to 70% of Opko’s float is held by either insiders or institutions, and it is doubtful that any of those shares will be put on the open market any time soon. And even if some are, the company’s founder and CEO, Dr. Phillip Frost, is picking shares at the same pace that shortsellers are borrowing them to sell.
OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics. The company develops various solutions to diagnose, treat, and prevent various conditions, counting point-of-care tests, molecular diagnostics tests, laboratory developed tests, and proprietary pharmaceuticals and vaccines. Its products comprise 4Kscore test that measures the blood plasma levels of four different prostate-derived kallikrein proteins.
At the end of Friday’s trade, Viacom, Inc. v(NASDAQ:VIAB)‘s shares dipped -3.13% to $56.41.
Nickelodeon and all related titles, characters and logos are trademarks of Viacom Inc. (NASDAQ: VIA, VIAB).
Nickelodeon and EyeBlack (www.eyeblack.com) recently declared an all-new partnership to bring beloved Nickelodeon characters to self-adhesive EyeBlack products. These new active, fun and dynamic products will comprise EyeBlack (under eye face decals), BattlePaint (face paint tubes), die cut stickers, and other decals that will allow the consumer to “sport” popular Nickelodeon characters counting SpongeBob SquarePants, Blaze and the Monster Machines, Bella and the Bulldogs and Teenage Mutant Ninja Turtles. All EyeBlack products are made in the USA.
EyeBlack’s products are typically worn by professional and collegiate athletes to reduce the glare of the sun on the field. By partnering with Nickelodeon, fans of SpongeBob, Teenage Mutant Ninja Turtles and more, will be able to sport their favorite characters on the field using EyeBlack’s high-end athletic products. These traditional athletic products are designed to be worn on the face to encourage more active play either outdoors or indoors.
Viacom Inc. operates as an entertainment content company in the United States and internationally. The company creates television programs, motion pictures, short-form video, applications, games, consumer products, social media, and other entertainment content. It operates in two segments, Media Networks and Filmed Entertainment.
Fifth Third Bancorp (NASDAQ:FITB), ended its Friday’s trading session with -0.75% loss, and closed at $21.14.
Fifth Third Bank declared the extension of its Brand of You integrated campaign, the details of which are accessible at www.53.com/BrandOfYou. Fifth Third Bank understands that getting a job is anything but easy, especially for recent grads, more than half of whom don’t have full-time jobs. On average, at least 200 people apply for every job opening and only two percent of applicants actually get an interview.* The Brand of You campaign aims to assist grads land jobs by offering job coaching scholarships from reemployment solutions company, NextJob, which are valued at $1,000 each.
Fifth Third Bancorp operates as a diversified financial services company in the United States. It operates through four segments: Commercial Banking, Branch Banking, Consumer Lending, and Investment Advisors. The Commercial Banking segment offers credit intermediation, cash administration, and financial services; lending and depository products; and foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers. The Branch Banking segment provides a range of deposit, loan, and lease products to individuals and small businesses.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.